Oncimmune LLC, manufacturer EarlyCD, Lung, and Blood Simple AIDS test that the doctors in assessing the risks and Early detection of lung cancer, announced today that the two And oral presentations during the last five co- This week the American College of Chest Physicians (ACCP) And the annual meeting in Vancouver, highlighting the collective Medical and economic advantages EarlyCDT and lungs. Oncimmune in EarlyCDT and lung cancer test uses a set of Antigens to detect the presence of immune biomarkers produced in the form of antibodies by the patient the immune system. Rise in one of the teams Biomarkers of the immune system (antibodies) above pre-Cut to a value that indicates that the tumor may be present.